Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAU 2020 | Highlights from EAU 2020

Peter Albers • 6 Aug 2020
EAU 2020
Bladder Cancer Genitourinary Cancer Prostate Cancer
ProPSMA

Peter Albers, MD, University Hospital of Düsseldorf, Düsseldorf, Germany, outlines key updates in the treatment and management of genitourinary cancers in the virtual EAU 2020 meeting including the ProPSMA study. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Peter Albers

3:14
Novel MRI approach for prostate cancer screening
Peter Albers • 8 Jul 2021
3:40
Surgery in metastatic germ cell tumors to reduce disease burden and improve long-term outcomes
Peter Albers • 8 Jul 2021
1:34
Current state of prostate cancer screening in Europe
Peter Albers • 8 Jul 2021
1:57
Challenges in prostate cancer screening
Peter Albers • 8 Jul 2021

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
0:45
SYNC-T combination immunotherapy in mCRPC
George Prendergast • 8 Apr 2024
0:40
PSMA PET findings in 225AC-J591-treated patients with mCRPC
Andres Ricaurte-Fajardo • 9 Apr 2024
0:45
Should radioligand therapies be used in earlier settings in prostate cancer?
Andres Ricaurte-Fajardo • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals